An update on novel quantitative techniques in the context of evolving whole-body PET imaging
- PMID: 25455879
- DOI: 10.1016/j.cpet.2014.09.004
An update on novel quantitative techniques in the context of evolving whole-body PET imaging
Abstract
Since its foundation PET has established itself as one of the standard imaging modalities enabling the quantitative assessment of molecular targets in vivo. In the past two decades, quantitative PET has become a necessity in clinical oncology. Despite introduction of various measures for quantification and correction of PET parameters, there is debate on the selection of the appropriate methodology in specific diseases and conditions. In this review, we have focused on these techniques with special attention to topics such as static and dynamic whole body PET imaging, tracer kinetic modeling, global disease burden, texture analysis and radiomics, dual time point imaging and partial volume correction.
Keywords: Glucose metabolism; Kinetic modeling; Quantification; Segmentation.
Copyright © 2015 Elsevier Inc. All rights reserved.
Similar articles
-
Partial volume correction of standardized uptake values and the dual time point in FDG-PET imaging: should these be routinely employed in assessing patients with cancer?Eur J Nucl Med Mol Imaging. 2007 Oct;34(10):1527-9. doi: 10.1007/s00259-007-0467-5. Eur J Nucl Med Mol Imaging. 2007. PMID: 17522857 No abstract available.
-
Assessment of treatment response using PET.PET Clin. 2015 Jan;10(1):9-26. doi: 10.1016/j.cpet.2014.09.002. Epub 2014 Oct 14. PET Clin. 2015. PMID: 25455877 Review.
-
Clinical evaluation of PET image reconstruction using a spatial resolution model.Eur J Radiol. 2013 May;82(5):862-9. doi: 10.1016/j.ejrad.2012.11.015. Epub 2012 Dec 17. Eur J Radiol. 2013. PMID: 23254158
-
Validation of fast-RAMLA in clinical PET.Ann Nucl Med. 2008 Dec;22(10):869-76. doi: 10.1007/s12149-008-0196-2. Epub 2009 Jan 8. Ann Nucl Med. 2008. PMID: 19142705
-
Quantification in clinical fluorodeoxyglucose positron emission tomography.Nucl Med Commun. 2004 Jul;25(7):647-50. doi: 10.1097/01.mnm.0000134327.85170.6b. Nucl Med Commun. 2004. PMID: 15208490 Review.
Cited by
-
PET in the management of locally advanced and metastatic NSCLC.Nat Rev Clin Oncol. 2015 Jul;12(7):395-407. doi: 10.1038/nrclinonc.2015.75. Epub 2015 Apr 28. Nat Rev Clin Oncol. 2015. PMID: 25917254 Review.
-
A prospective study of the feasibility of FDG-PET/CT imaging to quantify radiation-induced lung inflammation in locally advanced non-small cell lung cancer patients receiving proton or photon radiotherapy.Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):206-216. doi: 10.1007/s00259-018-4154-5. Epub 2018 Sep 18. Eur J Nucl Med Mol Imaging. 2019. PMID: 30229527
-
Application of 18F-NaF-PET/CT in assessing age-related changes in the cervical spine.Quant Imaging Med Surg. 2022 Jun;12(6):3314-3324. doi: 10.21037/qims-21-1174. Quant Imaging Med Surg. 2022. PMID: 35655822 Free PMC article.
-
Identify. Quantify. Predict. Why Immunologists Should Widely Use Molecular Imaging for Coronavirus Disease 2019.Front Immunol. 2021 May 13;12:568959. doi: 10.3389/fimmu.2021.568959. eCollection 2021. Front Immunol. 2021. PMID: 34054793 Free PMC article. Review.
-
What can be and what cannot be accomplished with PET to detect and characterize atherosclerotic plaques.J Nucl Cardiol. 2018 Dec;25(6):2012-2015. doi: 10.1007/s12350-017-0977-x. Epub 2017 Jul 10. J Nucl Cardiol. 2018. PMID: 28695405 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous